| Jennifer Michael Conway-brandt, | |
|
1212 N California St, Stockton, CA 95202-1552 | |
| (209) 468-8842 | |
| Not Available |
| Full Name | Jennifer Michael Conway-brandt |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 1212 N California St, Stockton, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073160339 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Michael Conway-brandt, 1212 N California St, Stockton, CA 95202-1552 Ph: (209) 468-8842 | Jennifer Michael Conway-brandt, 1212 N California St, Stockton, CA 95202-1552 Ph: (209) 468-8842 |
News Archive
Bethesda, MD-While there is never a bad time to address one's own obesity, if you're hoping to lose weight before conception for the sake of your child, here's some bad news: Some of the epigenetic damage might have already been done, even if you lose the weight just before conception.
Gov. Sam Brownback, Lt. Gov. Jeff Colyer and three Cabinet officials have scheduled a news conference for 10 a.m. Tuesday to describe details of their plan for making over the Kansas Medicaid program. ... The plan is expected to include a significant expansion of managed care.
CytoDel, Inc., a privately-held corporation, today announces the publication of preclinical data on the Company's lead product, Cyto-111, in the peer-reviewed journal, Science Translational Medicine. The complete text of the article titled, "Neuronal Delivery of Antibodies has Therapeutic Effects in Animal Models of Botulism," can be found here.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, today announced the initiation of a phase 2 study of its novel, investigational protein therapeutic, ACE-536, to treat patients with beta-thalassemia, a genetic hematologic disorder causing chronic and life-threatening anemia and serious complications affecting the spleen, liver and heart.
Results from a clinical trial of eteplirsen, a drug designed to treat Duchenne muscular dystrophy, suggest that the therapy allows participants to walk farther than people treated with placebo and dramatically increases production of a protein vital to muscle growth and health.
› Verified 6 days ago
Norman Love, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 8626 Lower Sacramento Rd Ste 41, Stockton, CA 95210 Phone: 209-478-2487 | |
Mrs. Cynthia Denise Aguilera, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 6707 Embarcadero Dr, Stockton, CA 95219 Phone: 209-956-4240 | |
Katherine Bailey, MA, MFTI Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 6707 Embarcadero Dr, Stockton, CA 95219 Phone: 209-956-4240 | |
Mrs. Taylere Louise Looney, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 540 N California St, Stockton, CA 95202 Phone: 209-464-4524 | |
Kristie Marie Rider, AMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 6707 Embarcadero Dr, Stockton, CA 95219 Phone: 209-604-8425 | |
Mr. Wayne A. Uecker, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1212 N California St, Stockton, CA 95202 Phone: 209-468-8834 | |
Davetta Jackson-young, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 8863 Santa Maria Way, Stockton, CA 95210 Phone: 678-704-5213 |